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background:  Prior studies have shown that insurance status plays a major role in the disparities observed in drug eluting stent (DES) use. 
We sought to assess impact of hospital & socio-demographic factors in patients with Medicare coverage.
methods:  We linked data from 2011-2012 Medicare Inpatient Discharges, Medicare Hospital Referral Region (HRR) Report (for population 
composition of each HRR), American Hospital Association (for hospital characteristics) & American Community Survey (for median income 
based on hospital zipcode). We analyzed DRG codes 249 (Bare Metal Stent without major complications/comorbidities [MCC]), 246 and 
247 (DES with and without MCC respectively). HRRs were classified as African American (AA), Hispanic and White dominant based on 
90th percentile cut off of AA and Hispanic population. We conducted logistic regression with Stata.
Results:  Among 322,002 discharges with DRG 246 (54,279), 247 (209,365) and 249 (58,358), higher odds of DES usage was observed 
in Hispanic dominant HRRs, zip codes with median income>$20,000, urban and western census regions. Lower odds of DES usage was 
seen in hospitals with higher volume of stent discharges and for-profit hospitals. No difference in DES usage was seen when comparing AA 
dominant with White dominant HRRs. From 2011 to 2012 total stent discharges decreased (168,023 > 153,979).
conclusion:  Our study delineates various hospital & socio-demographic factors that impact DES usage in a large national cohort of 
Medicare patients. 
Baseline Characteristics by Type of Stent 
Determinant Drug-eluting stent63,644 (81.9%)
Bare metal stent
58,358 (18.1%) P-value
White dominant
AA dominant
Hispanic dominant
AA & Hispanic dominant
206,372 (81.3%)
25,083 (81.2%)
29,595 (86.3%)
2,594 (86.9%)
47,466 (18.7%)
5,800 (18.8%)
4,700 (13.7%)
392 (13.1%)
<0.001
Median Income ≤$20,000
$20001-40000
$40001-60000
$60001-80000
≥$80001
6,081 (80.9%)
91,097 (82.1%)
98,641(81.7%)
39,362 (81.6%)
28,463 (82.4%)
1,438 (19.1%)
19,914 (17.9%)
22,032 (18.3%)
8,872 (18.4%)
6,102 (17.6%)
0.002
Total Stent Discharges
Quartile 1 (≤41)
Quartile 2 (42-84)
Quartile 3 (85-145)
Quartile 4 (>145)
14,987 (88%)
34,959 (81.6%)
61,816 (80.8%)
151,882 (81.9%)
2,054 (12%)
7,899 (18.4%)
14,717 (19.2%)
33,688 (18.1%)
<0.001
Bedsize Quartile 1 (≤190)
Quartile 2 (191-289)
Quartile 3 (290-428)
Quartile 4 (>428)
36,560 (82.5%)
47,780 (81.1%)
72,081 (83%)
107,223 (81.2%)
7,755 (17.5%)
11,140 (18.9%)
14,724 (17%)
24,739 (18.8%)
<0.001
Teaching hospital
Non-teaching hospital
167,128 (81.7%)
96,516 (82.2%)
37,447 (18.3%)
20,911 (17.8%) <0.001
Urban
Rural
243,304 (82%)
20,340 (81%)
53,574 (18 %)
4,784 (19%) <0.001
Government non-federal
Non-govt non-profit
Investor-owned for-profit
21,748 (82.4%)
200,571 (82%)
41,325 (80.9%)
4,648 (17.6%)
43,972 (18%)
9,738 (19.1%)
<0.001
Northeast US
Midwest US
South US
West US
45,173 (79.8%)
71,406 (81.4%)
110,073 (81.5%)
36,992 (86.8%)
11,403 (20.2%)
16,279 (18.6%)
25,027 (18.5%)
5,649 (13.2%)
<0.001
Significant Factors influencing drug eluting stent usage: Multivariate logistic regression model (Odds ratios)
(Referent: White dominant HRRs)
AA dominant
Hispanic dominant
AA and Hispanic dominant
-
1.01 (0.98-1.05)
1.37 (1.33-1.42) 
1.63 (1.47-1.82)
-
0.4
<0.001
<0.001 
(Referent: Income <$20,000)
Income $ 20,001-40,000
$ 40,001-60,000
$ 60,001-80,000
≥ $80,001
-
1.09 (1.03-1.16) 
1.06 (0.99-1.12)
1.02 (0.96-1.09)
1.08 (1.01-1.15) 
-
0.004
0.07
0.5
0.03
Total Stent Discharges Q 2 (42-84)
Quartile 3 (85-145)
Quartile 4 (>145) 
0.60 (0.57-0.63) 
0.58 (0.55-0.61) 
0.66 (0.63-0.69) 
<0.001
<0.001
<0.001 
Bedsize Quartile 2 (191-289)
Quartile 3 (290-428)
Quartile 4 (>428) 
0.93 (0.90-0.97) 
1.06 (1.02-1.09) 
0.92 (0.89-0.95) 
<0.001
0.002
<0.001 
(Referent: Government owned)
For profit hospital
-
0.88 (0.85-0.92) 
-
<0.001 
(Referent: Northeast US)
Midwest US
South US
West US 
-
1.17 (1.14-1.20) 
1.19 (1.16-1.23) 
1.65 (1.59-1.71) 
-
<0.001
<0.001
<0.001 
